A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

NCT02399072 · clinicaltrials.gov ↗
TERMINATED
Status
202
Enrollment
INDUSTRY
Sponsor class

Stopped There is no longer a plan to pursue an approval of lampalizumab.

Conditions

Interventions

Sponsor

Hoffmann-La Roche